|
|||||
|
|
The emerging role of serum/glucocorticoid-regulated kinases in cancer |
|
| Authors: | Pau Castel |
| Affiliation: | 1. Human Oncology &2. Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USA |
| Abstract: | |
| Keywords: | AKT drug resistance mTORC1 PI3K inhibitors PIK3CA SGK1 TSC2 |